XML 88 R69.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Equity (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | ---
Mar. 31, 2020 | Oct. 31, 2019 | Mar. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Mar. 31, 2022 | Feb. 28, 2021 | Dec. 31, 2018
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Weighted average grant date fair value (in Dollars per share) |  |  |  | $ 11.35 |  |  |  |  |
Covid 19, description | due to the potential impact on future net sales and operating results resulting from the COVID-19 pandemic, the estimated number of shares to be distributed, after forfeited shares, was reduced from 142,571 to 82,162. As the Company had already purchased shares in contemplation of the higher anticipated distribution, shares purchased in excess of the reduced anticipated distribution were transferred to treasury shares at the Interparfums SA level. |  |  |  |  |  |  |  |
Percentage of increase in annual dividend |  | 20.00% |  |  |  |  |  |  |
Dividends payable, amount per share (in Dollars per share) |  | $ 1.32 |  |  |  |  |  |  |
Subsequent Event [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Dividends payable, amount per share (in Dollars per share) |  |  |  |  |  |  | $ 0.50 |  |
Interparfums S A Subsidiary [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Adjusted for stock splits (in Shares) |  |  |  | 172,343 |  |  |  |  |
Revaluation resulted in reduction of cost, description |  |  | The original cost of the grant was approximately $4.4 million, and the March 2020 revaluation resulted in a reduction of the cost, to approximately $2.5 million. |  |  |  |  |  |
Modification resulted revised cost |  |  |  | $ 4,600,000 |  |  |  |  |
Board of Directors Chairman [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Dividends payable, amount per share (in Dollars per share) |  |  |  |  |  |  |  | $ 2.00 |
Interparfums S A Subsidiary [Member] | Employees [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Adjusted for stock splits (in Shares) |  |  |  |  |  |  |  |  | 26,600
Interparfums S A Subsidiary [Member] | Officers And Managers [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Aggregate intrinsic value of options outstanding |  |  |  |  |  |  |  |  | $ 133,000
Equity Option [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Number of shares available for grant (in Shares) |  |  |  | 612,535 |  |  |  |  |
Aggregate intrinsic value of options outstanding |  |  |  | $ 25,900,000 |  |  |  |  |
Term |  |  |  | 5 years |  |  |  |  |
Stock Option One [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Aggregate intrinsic value of options outstanding |  |  |  | $ 2,900,000 |  |  |  |  |
Equity Option [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Fair value of shares vested |  |  |  | $ 1,400,000 | $ 1,700,000 | $ 1,400,000 |  |  |
Weighted average grant date fair value (in Dollars per share) |  |  |  | $ 11.35 | $ 12.16 | $ 14.14 |  |  |
Minimum [Member] | Equity Option [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Share-based compensation arrangement by share-based payment award, award vesting period |  |  |  | 4 years |  |  |  |  |
Maximum [Member] | Equity Option [Member] |  |  |  |  |  |  |  |  |
Subsidiary or Equity Method Investee [Line Items] |  |  |  |  |  |  |  |  |
Share-based compensation arrangement by share-based payment award, award vesting period |  |  |  | 5 years |  |  |  |  |

X
- Definition Covid 19 description. + References No definition available. + Details
Name: | ipar_Covid19Description
Namespace Prefix: | ipar_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of increase in annual dividend. + References No definition available. + Details
Name: | ipar_PercentageOfIncreaseInAnnualDividend
Namespace Prefix: | ipar_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Revaluation resulted in reduction of cost description. + References No definition available. + Details
Name: | ipar_RevaluationResultedInReductionOfCostDescription
Namespace Prefix: | ipar_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The per share amount of a dividend declared, but not paid, as of the financial reporting date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586 + Details
Name: | us-gaap_DividendsPayableAmountPerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares authorized for issuance under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition An excess of the fair value of the modified award over the fair value of the award immediately before the modification. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)(iii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=ipar_InterparfumsSASubsidiaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=ipar_InterparfumsSASubsidiaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=ipar_EmployeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=ipar_OfficersAndManagersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=us-gaap_StockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=ipar_StockOptionOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |